샘플 요청 목록

 카트 문의
시장보고서
상품코드
1527987

세계의 유효성 시험 시장

Efficacy Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 689 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유효성 시험(Efficacy Testing) 시장은 2030년까지 12억 달러에 달할 전망

2023년 유효성 시험 시장 규모는 6억 20만 달러로 추정되고, 분석 기간 2023-2030년의 CAGR은 10.4%로 추이하며 성장하여, 2030년에는 12억 달러에 달할 것으로 예측됩니다. 유효성 시험 소모품은 본 보고서에서 분석하는 부문 중 하나이며 CAGR은 11.1%로 성장을 지속하고, 분석 기간이 끝날 때 7억 1,320만 달러에 달할 것으로 예측됩니다. 유효성 시험 장비 부문의 성장률은 분석 기간 동안 CAGR 9.3%로 추정됩니다.

미국 시장은 1억 8,450만 달러로 추정, 중국은 CAGR 12.0%로 성장할 것으로 예측

미국의 유효성 시험 시장은 2023년에 1억 8,450만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 1억7,190만 달러 규모에 이를 것으로 예측되며, 분석 기간 2023-2030년의 CAGR은 12.0%로 추정됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.9%와 9.6%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 10.1%로 성장할 것으로 예측됩니다.

세계 유효성 시험 시장 : 주요 동향 및 촉진요인 요약

유효성 시험이란 무엇인가, 제품 개발에 어떤 영향을 주는가?

유효성 시험은 특정 조건 하에서 제품이 의도한 목적을 달성할 수 있는지 여부를 체계적으로 평가하는 것을 말합니다. 이 프로세스는 의약품, 화장품, 건강 관리, 농약 등 다양한 산업에서 제품이 소비자에게 효과적이고 안전하다는 것을 보장하는 데 매우 중요합니다. 제약 산업에서 유효성 시험은 임상시험에 필수적인 요소이며, 신약이 일반적으로 승인되기 전에 치료 효과를 확립하기 위해 관리되는 환경에서 시험이 수행됩니다. 마찬가지로, 화장품 업계에서는 보습 효과와 안티 에이징 효과와 같은 수수께끼 같은 효과를 얻을 수 있는지 여부를 판단하기위한 시험을 실시했습니다. 조사 방법은 관리된 실험을 설정하고 특정 과학적으로 유효한 방법을 사용하여 선언된 주장에 대한 제품의 성능을 측정하는 것을 포함합니다. 이러한 엄격한 접근 방식은 소비자의 신뢰와 국제 규제 기준을 준수하고, 시장 진입을 원활하게 하고, 소비자의 안전과 관련된 법적 문제의 위험을 줄입니다.

현대의 기술은 어떻게 유효성 시험을 변화시키고 있는가?

첨단 기술의 출현으로 유효성 시험의 상황이 크게 변화하고 있습니다. 생명공학의 발전과 분자생물학의 혁신으로 더욱 정밀하고 효율적인 검사방법이 도입되었습니다. 예를 들어, 인간의 세포와 조직을 이용한 시험관내 시험은 특히 화장품 및 의약품 분야에서 윤리적인 우려와 규제 변화에 의해 기존의 동물 실험을 대체하는 시험법으로 보급되고 있습니다. 또한, 계산 모델링과 시뮬레이션은 신제품이 실제 시나리오에서 어떤 행동을 보이는지 예측하는 데 점점 더 많이 사용되고 있으며 개발 프로세스를 가속화하고 대규모 물리적 테스트의 필요성을 줄이고 있습니다. 이러한 기술은 시험의 정확성을 향상시킬 뿐만 아니라 연구 개발에 필요한 시간과 자원을 크게 줄여줍니다. 게다가 인공지능과 머신러닝의 통합은 데이터 분석을 효율화하고, 연구자들은 복잡한 생물학적 데이터를 신속하게 해석하고 새로운 화합물과 제품의 잠재적 효능에 대한 충분한 정보를 바탕으로 한 의사 결정을 할 수 있게 되었습니다.

오늘날 시장에서 유효성 시험이 직면하는 과제란?

기술 진보에도 불구하고, 유효성 시험은 효능과 신뢰성에 영향을 미치는 몇 가지 과제에 직면하고 있습니다. 그 중 하나가 국가마다 규제 요건이 다르다는 문제입니다. 기업은 다양한 규제 기준의 미로를 통과해야 하며 비용과 시간이 걸립니다. 게다가 특정 시험법, 특히 동물 실험을 둘러싼 윤리적 우려는 세계와 규제 당국의 감시를 계속하고 있으며, 산업계는 인도적이고 과학적으로 견조한 대안을 모색해야 합니다. 또, 특히 새로운 성분이나 기술이 잇달아 등장하는 가운데, 유효성 시험 방법을 급속히 진화하는 제품에 적응시키는 과제도 있습니다. 준수와 윤리 기준에 대한 적극적인 접근이 필요합니다.

유효성 시험 시장의 급속한 확대를 촉진요인은?

유효성 시험 시장의 성장은 승인 전에 제품의 유효성과 안전성에 대한 종합적인 증명을 필요로 하는 엄격한 규제 기준과 같은 여러 요인들에 의해 견인됩니다. 소비자의 의식이 높아지고 제품의 품질과 책임에 대한 요구가 높아짐에 따라 기업은 주장을 입증하기 위한 견고한 테스트에 투자하게 됩니다. 기술 진보는 중요한 역할을 하고 있으며, 높은 정확도와 효율성을 제공하는 새로운 테스트 방법을 통해 보다 신속한 제품 개발 사이클이 가능합니다. 맞춤형 의료와 주문제작 화장품의 대두도 중요한 추진력입니다. 이 분야에서는 개별 유전자 프로파일과 개인의 요구에 맞게 제품을 조정하는 정확한 유효성 시험이 필요하기 때문입니다. 또한 의약품, 화장품 등 산업이 신흥국 시장으로 세계로 확대되고 있기 때문에 현지 규제 요구에 대응하기 위한 유효성 시험의 양이 증가하고 있습니다. 이러한 요인은 생명공학과 분석기술의 지속적인 혁신과 결합되어 유효성 시험 시장을 지속적인 성장과 진화로 이끌고 있습니다.

조사 대상 기업 예(전 70건)

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Albany Molecular Research, Inc.
  • Intertek Group PLC
  • American Type Culture Collection(ATCC)
  • Almac Group
  • Eurofins Scientific SE
  • ALS Ltd.
  • Accugen Laboratories, Inc.
  • Himedia Laboratories
  • iuvo BioScience LLC
  • Campden BRI
  • Emsl Analytical, Inc.
  • American Testing Lab, Inc.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 남미
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 남미
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LYJ

Global Efficacy Testing Market to Reach US$1.2 Billion by 2030

The global market for Efficacy Testing estimated at US$600.2 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030. Efficacy Testing Consumables, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$713.2 Million by the end of the analysis period. Growth in the Efficacy Testing Instruments segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.5 Million While China is Forecast to Grow at 12.0% CAGR

The Efficacy Testing market in the U.S. is estimated at US$184.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$171.9 Million by the year 2030 trailing a CAGR of 12.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.9% and 9.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global Efficacy Testing Market - Key Trends & Drivers Summarized

What Is Efficacy Testing and How Does It Impact Product Development?

Efficacy testing refers to the systematic evaluation of whether a product achieves its intended purpose under specified conditions. This process is critical across various industries, including pharmaceuticals, cosmetics, healthcare, and agricultural chemicals, to ensure that products are both effective and safe for consumer use. In the pharmaceutical industry, efficacy testing is an integral part of clinical trials, where new drugs are tested in controlled environments to establish their therapeutic effects before they can be approved for public use. Similarly, in cosmetics, these tests determine if products meet the claimed benefits, such as moisturizing or anti-aging effects. The methodology of efficacy testing involves setting up controlled experiments and utilizing specific, scientifically valid methods to measure product performance against declared claims. This rigorous approach helps to maintain consumer trust and compliance with international regulatory standards, thereby facilitating smoother market entries and reducing the risk of legal issues related to consumer safety.

How Are Modern Technologies Revolutionizing Efficacy Testing?

With the advent of advanced technologies, the landscape of efficacy testing is undergoing significant transformation. Biotechnological developments and innovations in molecular biology have introduced more precise and efficient testing methods. For instance, in vitro testing using human cells and tissues is becoming a popular alternative to traditional animal tests, especially in the cosmetics and pharmaceutical sectors, due to ethical concerns and regulatory changes. Additionally, computational modeling and simulation are increasingly used to predict how new products will behave in real-world scenarios, which accelerates the development process and reduces the need for extensive physical trials. These technologies not only enhance the accuracy of tests but also significantly decrease the time and resources required for research and development. Furthermore, the integration of artificial intelligence and machine learning has begun to streamline data analysis, allowing researchers to quickly interpret complex biological data and make informed decisions about the potential efficacy of new compounds or products.

What Challenges Does Efficacy Testing Face in Today's Global Market?

Despite technological advancements, efficacy testing faces several challenges that can impact its effectiveness and reliability. One major issue is the variability of regulatory requirements across different countries, which can complicate the process for products intended for international markets. Companies must navigate a maze of diverse regulatory standards, which can be both costly and time-consuming. Additionally, the ethical concerns surrounding certain testing methods, particularly animal testing, continue to generate public and regulatory scrutiny, prompting industries to seek alternative methods that are both humane and scientifically sound. There is also the challenge of adapting efficacy testing methodologies to rapidly evolving products, especially as new ingredients and technologies continuously emerge. These factors necessitate ongoing adaptations in testing protocols and a proactive approach to regulatory compliance and ethical standards in product development.

What Drives the Rapid Expansion of the Efficacy Testing Market?

The growth in the efficacy testing market is driven by several factors, including stringent regulatory standards that require comprehensive proof of product effectiveness and safety before approval. Increased consumer awareness and demand for quality and accountability in products also push companies to invest in robust testing to substantiate their claims. Technological advancements play a critical role, with new testing methods that offer greater accuracy and efficiency, thus allowing for more rapid product development cycles. The rise in personalized medicine and custom cosmetics is another significant driver, as these fields require precise efficacy testing to tailor products to individual genetic profiles and personal needs. Additionally, the global expansion of industries such as pharmaceuticals and cosmetics into emerging markets is increasing the volume of efficacy testing to meet local regulatory demands. These factors, combined with the ongoing innovation in biotechnology and analytical techniques, are propelling the efficacy testing market toward sustained growth and evolution.

Select Competitors (Total 70 Featured) -

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Charles River Laboratories International, Inc.
  • Albany Molecular Research, Inc.
  • Intertek Group PLC
  • American Type Culture Collection (ATCC)
  • Almac Group
  • Eurofins Scientific SE
  • ALS Ltd.
  • Accugen Laboratories, Inc.
  • Himedia Laboratories
  • iuvo BioScience LLC
  • Campden BRI
  • Emsl Analytical, Inc.
  • American Testing Lab, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Efficacy Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • A Prelude to Efficacy Testing
    • Global Efficacy Testing Market Poised for Steady Growth
    • US Dominates, Asia-Pacific to Witness Rapid Growth
    • Anti-microbial/Preservative Efficacy Testing to Register Rapid Growth
    • Disinfectant Efficacy Testing Dominates
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Importance of Preservative Efficacy Testing
    • Preservation Technique for Paraben-Free Cosmetics
    • Development of Alternative Techniques of Preservation
    • Adoption of Hurdle Technology
    • Preservative Systems in Liquid Dietary Supplements
    • Preservative Efficacy Test (PET) for Cosmetics
    • Efficacy Testing for Cosmetics
    • Techniques Employed for Demonstrating Effectiveness of Disinfectants
    • Categorization of Test Types
    • Surface Testing
    • Additional Tests Mandated for the Pharmaceuticals Industry by the USP
    • Contact Time Defined
    • Strong Rise in Pharmaceutical Sales to Drive Demand for Efficacy Testing
    • Global Prescription Drug Sales (In US$ Billion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Rapid Growth of Generic Drugs Drives Demand for Pharma Efficacy Testing
    • Global Generic Drugs Market Size (in $ Billion) for the Years 2016, 2019, 2020 & 2025
    • Aging Population Propels the Demand for Ethicacy Testing in End-use Applications
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Increasing Healthcare Expenditure to Foster Growth
    • World Healthcare Expenditure (In US$ Trillion) for the Years 2020 & 2024
    • Persistent Increase in Pharmaceutical R&D Bodes Well for Efficacy Testing
    • Rising Incidence of Chronic Diseases Fuels Demand for Efficacy Testing
    • Global Cancer Incidence by Region: 2024
    • Rising Diabetes Prevalence Presents Opportunity for Cell Harvesting: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Disinfectant Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Disinfectant Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Disinfectant Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Antimicrobial Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Antimicrobial Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Antimicrobial Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharmaceutical Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Pharmaceutical Manufacturing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Pharmaceutical Manufacturing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Cosmetics & Personal Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Cosmetics & Personal Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Cosmetics & Personal Care Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Efficacy Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Efficacy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • Consumables Segment Leads the Market

III. MARKET ANALYSIS

  • UNITED STATES
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • JAPAN
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • CHINA
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • EUROPE
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Efficacy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Efficacy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • GERMANY
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Efficacy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • INDIA
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Efficacy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Efficacy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Efficacy Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030
  • AFRICA
    • Efficacy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Efficacy Testing by Segment - Consumables, Instruments and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Efficacy Testing by Segment - Consumables, Instruments and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Efficacy Testing by Segment - Percentage Breakdown of Value Sales for Consumables, Instruments and Services for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Efficacy Testing by Type - Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Efficacy Testing by Type - Percentage Breakdown of Value Sales for Disinfectant Efficacy Testing and Antimicrobial Efficacy Testing for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Efficacy Testing by Application - Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Efficacy Testing by Application - Percentage Breakdown of Value Sales for Pharmaceutical Manufacturing, Cosmetics & Personal Care Products and Medical Devices for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제